Work Medical Technology Group LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Investor Habbas Kelly Khalid filed an amendment to Schedule 13G reporting zero beneficial ownership in WORK Medical Technology Group LTD.
NASDAQ
Kelly Habbas has filed a Schedule 13G, reporting beneficial ownership of 369,000 Class A Ordinary Shares, representing 21.5% of the class, in WORK Medical Technology Group LTD.
NASDAQ
Trillium Trading, LLC has filed a Schedule 13G amendment, reporting no beneficial ownership of Class A Ordinary Shares in WORK Medical Technology Group LTD.
NASDAQ
Trillium Trading, LLC has reported beneficial ownership of 18% of WORK Medical Technology Group LTD's Class A Ordinary Shares as of June 3, 2026.
NASDAQ
Kelly Habbas has reported beneficial ownership of 325,000 Class A Ordinary Shares in WORK Medical Technology Group LTD, representing 18.9% of the class.
NASDAQ
SCHEDULE 13G/A: L1 Capital Divests Entire Stake in WORK Medical
L1 Capital Global Opportunities Master Fund, Ltd. has reported a complete divestment of its Class A Ordinary Shares in WORK Medical Technology Group LTD, reducing its beneficial ownership to 0%.
NASDAQ
Bigger Capital Fund, LP and its affiliates have reported a complete divestment of their beneficial ownership in WORK Medical Technology Group LTD's Class A Ordinary Shares.
NASDAQ
L1 Capital Global Opportunities Master Fund, Ltd. has reported a 9.99% passive beneficial ownership stake in WORK Medical Technology Group LTD's Class A Ordinary Shares.
NASDAQ
Bigger Capital Fund, LP, along with its general partner and managing member, reported a 9.99% beneficial ownership in WORK Medical Technology Group LTD's Class A Ordinary Shares.
NASDAQ
LWY GROUP LTD and its sole shareholder Baiming Yu have disclosed a beneficial ownership of 42.83% in WORK Medical Technology Group LTD, totaling 6,250,000 ordinary shares as of December 31, 2024.